Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
Pharmacol Res
; 86: 11-7, 2014 Aug.
Article
en En
| MEDLINE
| ID: mdl-24798679
Palabras clave
(4-Phenylphenyl)methyl N-[(2S,3R)-2-methyl-4-oxooxetan-3-yl]carbamate (PubChem CID: 73291988); 3-Phenyl-1-pyrrolidin-1-ylpropan-1-one (PubChem CID: 1533088); 5-Phenylpentyl N-[(2S,3R)-2-methyl-4-oxooxetan-3-yl]carbamate (PubChem CID: 57523549); Fatty acid ethanolamides; Inflammation; N-Acylethanolamine acid amidase; N-Pentadecylbenzamide (PubChem CID: 44398681); N-Pentadecylcyclohexancarboxamide (PubChem CID: 44398718); N-[(3S)-2-Oxooxetan-3-yl]-3-phenylpropanamide (PubChem CID: 25227533); N-[(3S)-2-Oxooxetan-3-yl]-4-phenylbenzamide (PubChem CID: 46899632); NAAA inhibitors; Oleoylethanolamide (PubChem CID: 5283454); Pain; Palmitoylethanolamide; Palmitoylethanolamide (PubChem CID: 4671); Pentadecylamine (PubChem CID: 17386)
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores Enzimáticos
/
Amidohidrolasas
/
Analgésicos
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Pharmacol Res
Asunto de la revista:
FARMACOLOGIA
Año:
2014
Tipo del documento:
Article